Home/Investors/Sanofi

Sanofi

Biotech Investor · 7 portfolio companies

Portfolio

7

Combined Value

$10.5B

Focus Areas

13

Top Stage

Phase 2

Investment Focus

Immunology Oncology Autoimmune Orphan Diseases Autoimmune Diseases Glioblastoma Colorectal Cancer Breast Cancer Oncology/Hematology Allergy/Inflammation Fibrotic Diseases Central Nervous System (CNS) Diseases Metabolic Syndromes

Portfolio Companies

Company	Stage	Valuation	Focus
Kymera Therapeutics	Phase 1b	$7.0B	Immunology, Oncology
Inhibrx Biosciences	Phase 2	$1.8B	Oncology, Orphan Diseases
Nurix Therapeutics	Phase 2	$1.7B	Oncology, Autoimmune Diseases
Owkin	Approved	—	Oncology, Glioblastoma
Blueprint Medicines	Commercial	—	Oncology/Hematology, Allergy/Inflammation
Graviton Bioscience	Phase 2	—	Fibrotic Diseases, Autoimmune Diseases
Enable Injections	Commercial	—	—

Frequent Co-Investors

Cathay Innovation1 shared Public market investors1 shared F-Prime Capital1 shared Bristol Myers Squibb (BMS)1 shared Google Ventures1 shared Bpifrance Large Ventures1 shared FRST Capital1 shared NJF Holdings1 shared